Building a future for curative cell therapies

Dec 31, 2025

In a two-part Off Script podcast, CTMC CEO Jason Bock discusses the manufacturing and operational shifts needed to scale autologous cell therapies.

The Wealthing Podcast

Jun 29, 2026

Alicia Castillo Holley hosts Jason Bock on her show. Curative Intent: on Engineering T-Cells, Patient Impact, and Chasing the Impossible. The...

Jun 24, 2026

By Jason Bock, Ph.D., CEO, and Duane Avant, CTO, CTMC Manufacturing autologous cell therapies requires close coordination with clinical staff, as...

May 27, 2026

Read the full article here: Pharma's Almanac

Back